The document AT-08 has been updated following the publication of Execution regulation (EU) 994/2020. As a result, the tables at point IV have been revised.

As a reminder, companies who place medicated premixtures and/or additives on the market, and possessing the results of the relative wall adhesion tests, may communicate them to OVOCOM by email (info@ovocom.be).

Companies must also ensure that results, previously communicated, are updated. After evaluation, they will be incorporated in document ‘AT-08 – Cross-Contamination’.

During this revision, the maximum Co content of the final compound feed potentially containing a cobalt-based tracer was also updated (point 2.2.1.9).

The changes in this document are highlighted in gray.